Charlotte, NC-based Sealed Air Corporation, a manufacturer of food and protective packaging solutions, has agreed to be acquired by private investment firm Clayton, Dubilier & Rice (CD&R) in an ...
Clayton, Dubilier & Rice — the private investment firm behind some of the biggest distribution and industrial manufacturing transactions over the past decade — announced Nov. 21 that it has appointed ...
Sealed Air's (SEE) sale to CD&R could see some investor pushback as the price is likely below expectations, according to a Wolfe Research analyst. "We sense that the deal value is below most buy-side ...
Resideo technologies (REZI) sees buys worth $35.2m by CD&R group ...
Investing.com -- Private equity firm Clayton Dubilier & Rice has entered the competition to acquire Castrol, BP (NYSE:BP)’s lubricant business valued at approximately $8 billion, according to Sky News ...
(IN BRIEF) Sanofi has completed the sale of a 50.0% controlling stake in its consumer healthcare division, Opella, to CD&R, creating a global leader in consumer healthcare. Sanofi retains a ...
ESR patch PS2 games, and burn them to DVD-R. Master Disc patch PS2 games, and burn them to CD-R or DVD-R. LibCrypt patch PS1 games, and burn them to a CD-R. PSX 80 Minute patch PS1 or PS2 games, and ...
The private equity backer of Motor Fuel Group (MFG), one of Britain's biggest petrol forecourt empires, is exploring the sale of a stake in a deal that could value it at about £7bn. Sky News has ...
CD&R, the private equity owner of Focus Financial Partners, has tapped Charles Schwab’s former CFO, Peter Crawford, as an operating advisor to help evaluate and select new investments in the financial ...
* Investments in securities are subject to market risks. These are indicative and should not be interpreted as investment advice or guaranteed returns.
Sanofi SNY has entered into exclusive negotiations with U.S.-based private equity company Clayton Dubilier & Rice (CD&R) for the potential sale of a 50% controlling stake in its consumer healthcare ...
SANOFI said on Monday (Oct 21) it had entered exclusive talks for the sale of a 50 per cent controlling stake in its consumer health business Opella to US private equity firm Clayton Dubilier & Rice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results